Figure 3: Structure of sitagliptin (Dibbern HW, et al ., 2002) Figure 4: Sitagliptin mechanism of action (Makrilakis K, 2019) Repaglinide Type 2 diabetes treatment with a BCS class II medication
Summer is herebringing sunshine, warmer weather, and an abundance of delicious, vibrant produce
As a result, they become more vulnerable to oxidative damage, eventually resulting in the death of -cells and it is clearly showing that there is a clear connection between oxidative stress, mitochondrial dysfunction, and T2D (Rocha et al., 2020)
This spring, on an earnings call with Pepsi, the daughter of an analystwho was with her dad for Bring Your Kid to Work Dayhad one question for the CEO of the beverage giant: So what do you think about the launch of GLP-1 oral medications coming to market next year? If only the Gila monster could talk
You also need to consider that you may need to take a GLP-1 for a long time, or maybe forever